These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31075522)

  • 1. Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI study.
    Menghini-Müller S; Studerus E; Ittig S; Heitz U; Egloff L; Andreou C; Valmaggia LR; Kempton MJ; van der Gaag M; de Haan L; Nelson B; Barrantes-Vidal N; Nordentoft M; Ruhrmann S; Sachs G; Rutten BP; Os JV; Riecher-Rössler A; ; McGuire P; Valmaggia LR; Kempton MJ; Calem M; Tognin S; Modinos G; de Haan L; van der Gaag M; Velthorst E; Kraan TC; van Dam DS; Burger N; Nelson B; McGorry P; Amminger GP; Pantelis C; Politis A; Goodall J; Riecher-Rössler A; Borgwardt S; Rapp C; Ittig S; Studerus E; Smieskova R; Bressan R; Gadelha A; Brietzke E; Asevedo G; Asevedo E; Zugman A; Barrantes-Vidal N; Domínguez-Martínez T; Racioppi A; Cristóbal-Narváez P; Kwapil TR; Monsonet M; Kazes M; Daban C; Bourgin J; Gay O; Mam-Lam-Fook C; Krebs MO; Nordholm D; Randers L; Krakauer K; Glenthøj L; Glenthøj B; Nordentoft M; Ruhrmann S; Gebhard D; Arnhold J; Klosterkötter J; Sachs G; Lasser I; Winklbaur B; Delespaul PA; Rutten BP; van Os J
    Eur Psychiatry; 2019 Jun; 59():52-59. PubMed ID: 31075522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis.
    Fusar-Poli P; Nelson B; Valmaggia L; Yung AR; McGuire PK
    Schizophr Bull; 2014 Jan; 40(1):120-31. PubMed ID: 23180756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in first self-perceived signs and symptoms in patients with an at-risk mental state and first-episode psychosis.
    Heitz U; Studerus E; Menghini-Müller S; Papmeyer M; Egloff L; Ittig S; Navarra A; Andreou C; Riecher-Rössler A
    Early Interv Psychiatry; 2019 Jun; 13(3):582-588. PubMed ID: 29235240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Relative Importance of Family History, Gender, Mode of Onset, and Age at Onsetin Predicting Clinical Features of First-Episode Psychotic Disorders.
    Compton MT; Berez C; Walker EF
    Clin Schizophr Relat Psychoses; 2017; 11(3):143-150. PubMed ID: 25367167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
    Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
    Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
    Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
    Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in cognitive functioning of patients at-risk for psychosis and healthy controls: Results from the European Gene-Environment Interactions study.
    Menghini-Müller S; Studerus E; Ittig S; Valmaggia LR; Kempton MJ; van der Gaag M; de Haan L; Nelson B; Bressan RA; Barrantes-Vidal N; Jantac C; Nordentoft M; Ruhrmann S; Sachs G; Rutten BP; van Os J; Riecher-Rössler A;
    Eur Psychiatry; 2020 Mar; 63(1):e25. PubMed ID: 32167444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and clinical correlates of substance use disorders in first episode psychosis.
    Brunette MF; Mueser KT; Babbin S; Meyer-Kalos P; Rosenheck R; Correll CU; Cather C; Robinson DG; Schooler NR; Penn DL; Addington J; Estroff SE; Gottlieb J; Glynn SM; Marcy P; Robinson J; Kane JM
    Schizophr Res; 2018 Apr; 194():4-12. PubMed ID: 28697856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco use in first-episode psychosis, a multinational EU-GEI study.
    Sánchez-Gutiérrez T; Rodríguez-Toscano E; Roldán L; Ferraro L; Parellada M; Calvo A; López G; Rapado-Castro M; La Barbera D; La Cascia C; Tripoli G; Di Forti M; Murray RM; Quattrone D; Morgan C; van Os J; García-Portilla P; Al-Halabí S; Bobes J; de Haan L; Bernardo M; Santos JL; Sanjuán J; Arrojo M; Ferchiou A; Szoke A; Rutten BP; Stilo S; D'Andrea G; Tarricone I; ; Díaz-Caneja CM; Arango C
    Psychol Med; 2023 Nov; 53(15):7265-7276. PubMed ID: 37185055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety Symptoms in Psychotic Disorders: Results from the Second Australian National Mental Health Survey.
    Bosanac P; Mancuso SG; Castle DJ
    Clin Schizophr Relat Psychoses; 2016; 10(2):93-100. PubMed ID: 27440210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
    Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
    Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis.
    Schirmbeck F; van der Burg NC; Blankers M; Vermeulen JM; McGuire P; Valmaggia LR; Kempton MJ; van der Gaag M; Riecher-Rössler A; Bressan RA; Barrantes-Vidal N; Nelson B; Amminger GP; McGorry P; Pantelis C; Krebs MO; Ruhrmann S; Sachs G; Rutten BPF; van Os J; Nordentoft M; Glenthøj B; ; Fusar-Poli P; de Haan L
    Schizophr Bull; 2022 Jan; 48(1):100-110. PubMed ID: 34417795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in the psychopathology of emerging psychosis.
    González-Rodríguez A; Studerus E; Spitz A; Bugra H; Aston J; Borgwardt S; Rapp C; Riecher-Rossler A
    Isr J Psychiatry Relat Sci; 2014; 51(2):85-92. PubMed ID: 25372557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function.
    Zink M; Schirmbeck F; Rausch F; Eifler S; Elkin H; Solojenkina X; Englisch S; Wagner M; Maier W; Lautenschlager M; Heinz A; Gudlowski Y; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Juckel G; Krueger-Oezguerdal S; Wobrock T; Hasan A; Riedel M; Müller H; Klosterkötter J; Bechdolf A
    Acta Psychiatr Scand; 2014 Sep; 130(3):214-26. PubMed ID: 24571191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [First-episodes psychosis: clinical and epidemiological news].
    Tournier M
    Encephale; 2013 Sep; 39 Suppl 2():S74-8. PubMed ID: 24084425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patients with an increased risk of developing a first psychotic episode: two cases].
    Cohen G; Klaassen RM; Rietdijk J; Dragt S; van der Gaag M
    Tijdschr Psychiatr; 2012; 54(5):471-4. PubMed ID: 22588962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Psychosis Spectrum in 22q11.2 Deletion Syndrome Is Comparable to That of Nondeleted Youths.
    Tang SX; Moore TM; Calkins ME; Yi JJ; Savitt A; Kohler CG; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Gur RC; Gur RE
    Biol Psychiatry; 2017 Jul; 82(1):17-25. PubMed ID: 27832840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder.
    Willhite RK; Niendam TA; Bearden CE; Zinberg J; O'Brien MP; Cannon TD
    Schizophr Res; 2008 Sep; 104(1-3):237-45. PubMed ID: 18573639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study.
    Brostedt EM; Msghina M; Persson M; Wettermark B
    BMC Psychiatry; 2017 Dec; 17(1):416. PubMed ID: 29284436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.